Relevance tier by entity

Entity Tier Description
DLBCL 2 aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous1

Mutation incidence in large patient cohorts (GAMBL reanalysis)

Entity source frequency (%)
DLBCL GAMBL genomes 1.15
DLBCL Schmitz cohort 1.70
DLBCL Reddy cohort 1.60
DLBCL Chapuy cohort 0.85

Mutation pattern and selective pressure estimates

Cannot include /dnds_P2RX5.md - does not exist yet

aSHM regions

chr_name hg19_start hg19_end region regulatory_comment
chr17 3597616 3599572 TSS active_promoter

Cannot include /browser_P2RX5.md - does not exist yet

Expression

All Mutations

RG116

Cannot include /mermaid_P2RX5.md - does not exist yet

References

1.
Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC, Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A, Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL, Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood. 2013 Aug 15;122(7):1256–1265. PMCID: PMC3744992